Steven H. Collis is Chairman, President and CEO of AmerisourceBergen Corporation, a global healthcare solutions leader, currently ranked No. 10 on the Fortune 500. He was elected president and CEO in 2011 and chairman in 2016.
 
Under Mr. Collis’ leadership, AmerisourceBergen has experienced tremendous financial growth. The company’s annual revenue has jumped more than 80% during Mr. Collis’ tenure as CEO and its number of employees has risen to 42,000, with offices in more than 50 countries worldwide.
 
Several strategic investments and acquisitions enabled the company to expand its breadth of services and solutions resulting in unprecedented customer partnerships, global reach, and deep expertise that is shaping the equity, innovation, and access of healthcare in a meaningful way.
 
In 2012, AmerisourceBergen acquired World Courier, the premier global specialty provider of transportation, storage and distribution services for global clinical trials. The addition of World Courier’s unique capabilities and expertise to the existing commercialization services within AmerisourceBergen only further strengthened the company’s worldwide offerings to global biopharma partners, and provided an established platform to expand specialty services outside North America for the first time in company history.
 
AmerisourceBergen’s agreement with Walgreens Boots Alliance (WBA) in 2013 marked an industry first—with a national pharmacy chain turning over all its pharmaceutical distribution to a wholesaler and collaborating on a global basis for generic product sourcing.
 
The company’s 2015 acquisition of MWI Veterinary Supply further reflect AmerisourceBergen’s ability to deliver value in diverse aspects of patient care and growing markets. As a result, the Wall Street Journal named Mr. Collis as the best performing chief executive in the Philadelphia region for 2015, and Barron’s ranked AmerisourceBergen two years in a row as No. 1 on their list of the 500 top performing companies.
 
In 2021, AmerisourceBergen extended and expanded upon its long-term strategic customer relationship with WBA and completed the acquisition of European-based company, Alliance Healthcare. The acquisition enhanced AmerisourceBergen’s reach and solutions within pharmaceutical distribution, increased the breadth of its global manufacturer services, and further advanced the company’s ability to provide innovative, global healthcare solutions for all its customers and patient populations around the world.
 
Mr. Collis has additionally forged a clear path in fulfilling AmerisourceBergen’s purpose of being united in our responsibility to create healthier futures. He spearheaded the creation of the AmerisourceBergen Foundation, the company’s first enterprise-wide, nonprofit charitable organization, which supports health-related causes that enrich the global community. Under his leadership, the company’s commitment to diversity, equity and inclusion continues to be recognized, with AmerisourceBergen being named a DiversityInc Noteworthy Company in 2017, 2018, 2019, 2021, and 2022. The company was also honored by the Women’s Forum of New York as a leading company for gender balance on its board of directors.
 
Mr. Collis’ career with AmerisourceBergen spans more than two decades and includes time leading the company’s specialty and wholesale distribution and related services businesses. He helped found the former Specialty Group business in 1994 and grew it into the market leader in specialty pharmaceutical distribution and product commercialization services.
 
Mr. Collis earned a Bachelor of Commerce with Honors degree from the University of Witwatersrand in Johannesburg, South Africa. In addition to serving as chairman of AmerisourceBergen’s board of directors, he serves on the board of the International Federation of Pharmaceutical Wholesalers. Mr. Collis is a founding vice chairman of the American Cancer Society’s CEOs Against Cancer Pennsylvania chapter and serves on the Board of Governors for the American Red Cross.